Lyell Immunopharma, Inc. (LYEL) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -38.51M | -32.25M | -28.58M | -34.46M | -54.74M | -47.24M | -35.04M | -38.09M | -42.02M | -40.63M | -37.69M | -39.16M | -46.21M | -40.27M | -37.1M | -44.33M | -47.85M | -33.17M | -25.49M | -33.95M |
| Operating CF Margin % | -1925500% | -537516.67% | -190513.33% | -430725% | -781971.43% | -429472.73% | -103064.71% | -293030.77% | -1400533.33% | -312576.92% | -150744% | -145040.74% | -71095.38% | -83.22% | -1236766.67% | -124.04% | -8653.16% | -1175.51% | -925.3% | -1291.74% |
| Operating CF Growth % | 29.65% | 31.73% | 18.45% | 9.54% | -30.28% | -16.26% | 7.02% | 2.72% | 9.08% | -0.91% | -1.57% | 11.67% | 3.43% | -21.38% | -45.55% | -30.59% | -42.43% | -24.09% | - | - |
| Net Income | -24.15M | -140.72M | -38.85M | -42.68M | -52.2M | -191.94M | -44.58M | -45.81M | -60.67M | -52.93M | -50.85M | -63.89M | -66.96M | -8.4M | -70.25M | -36.32M | -68.14M | -83.71M | -48.88M | -62.59M |
| Depreciation & Amortization | 2.33M | 2.4M | 2.57M | 3.13M | 3.44M | 5.03M | 4.68M | 4.9M | 5.02M | 5.06M | 5.1M | 4.54M | 5.03M | 4.59M | 4.17M | 3.73M | 3.97M | 3.99M | 4.09M | 3.01M |
| Stock-Based Compensation | 0 | 25.57M | 5.23M | 5M | 6.02M | 8.08M | 7.62M | 8.28M | 9.15M | 8.46M | 10.52M | 0 | 13.88M | 0 | 0 | 0 | 0 | 0 | 13.04M | 15.25M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -15.61M | 79.83M | 2.61M | 963K | -2.45M | 131.55M | -3.8M | -4.52M | 7.71M | -2.95M | -4.88M | 16.61M | 6.15M | 6.93M | 27.23M | 26.24M | 18.71M | 42.92M | 511K | 10.95M |
| Working Capital Changes | -1.08M | 672K | -136K | -876K | -9.55M | 34K | 1.04M | -954K | -3.24M | 1.72M | 2.43M | 3.58M | -4.31M | -43.39M | 1.75M | -37.98M | -2.39M | 3.62M | 5.74M | -565K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.38M | 325K | -779K | -231K | -1.65M | -2.04M | -568K | -517K | -113K | 425K | -1.41M | 380K | 2.07M | -526K | 23K | -1.77M | 2.94M | 99K | -988K | 346K |
| Cash from Investing | 17.38M | -31.36M | 3.35M | 12.65M | 69.47M | 53.51M | 1.92M | 45.01M | 21.99M | -100.69M | 99.67M | 152.91M | 32.15M | 46.65M | -57.09M | 25.02M | -26.12M | -73.9M | -144.91M | -39.47M |
| Capital Expenditures | -89K | -304K | -62K | -168K | -246K | -44K | -59K | -331K | -30K | -25K | -195K | -933K | -1.53M | -4.58M | -2.79M | -7.17M | -9.73M | -10.27M | -11.6M | -24.45M |
| CapEx % of Revenue | 4450% | 5066.67% | 413.33% | 2100% | 3514.29% | 400% | 173.53% | 2546.15% | 1000% | 192.31% | 780% | 3455.56% | 2358.46% | 9.47% | 93033.33% | 20.06% | 1760.04% | 363.86% | 421.02% | 930.25% |
| Acquisitions | 0 | 0 | 263K | 0 | 0 | -31.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -40K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -41.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -275.35M | -215.9M |
| Cash from Financing | 51.72M | 222K | 50M | 183K | 1K | 437K | 0 | 862K | 27K | 759K | -143K | 1.2M | -69K | 863K | 4.76M | 2.46M | 2.56M | 7.4M | -531K | 393.49M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 51.72M | 223K | 50M | 184K | 0 | 437K | 0 | 862K | 103K | 882K | 72K | 1.25M | 0 | 1.84M | 5.13M | 1.57M | 2.56M | 7.4M | -1.06M | 392.86M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -1K | 0 | -1K | 1K | 0 | 0 | 0 | -76K | -123K | -215K | -50K | -69K | -981K | -367K | 887K | 0 | 0 | 529K | 630K |
| Net Change in Cash | 30.59M | -63.39M | 24.77M | -21.63M | 14.73M | 5.3M | -33.12M | 7.77M | -20M | -140.57M | 61.84M | 114.95M | -14.13M | 7.24M | -89.43M | -16.86M | -71.23M | -99.68M | -170.94M | 320.07M |
| Free Cash Flow | -38.6M | -32.55M | -28.64M | -34.63M | -54.98M | -47.29M | -35.1M | -38.42M | -42.05M | -40.66M | -37.88M | -40.09M | -47.74M | -44.85M | -39.89M | -51.5M | -57.59M | -43.44M | -37.09M | -58.39M |
| FCF Margin % | -1929950% | -542583.33% | -190926.67% | -432825% | -785485.71% | -429872.73% | -103238.24% | -295576.92% | -1401533.33% | -312769.23% | -151524% | -148496.3% | -73453.85% | -92.69% | -1329800% | -144.1% | -10413.2% | -1539.37% | -1346.32% | -2221.99% |
| FCF Growth % | 29.8% | 31.15% | 18.41% | 9.89% | -30.77% | -16.3% | 7.34% | 4.16% | 11.94% | 9.34% | 5.05% | 22.15% | 17.09% | -3.24% | -7.56% | 11.8% | -9.09% | 15.83% | - | - |
| FCF per Share | -1.76 | -1.90 | -1.57 | -2.34 | -3.73 | -3.55 | -2.74 | -3.01 | -3.31 | -3.21 | -3.01 | -3.20 | -3.83 | -3.59 | -3.21 | -4.18 | -4.72 | -3.58 | -3.09 | -4.90 |
| FCF Conversion (FCF/Net Income) | 1.59x | 0.23x | 0.74x | 0.81x | 1.05x | 0.25x | 0.79x | 0.83x | 0.69x | 0.77x | 0.74x | 0.61x | 0.69x | 4.80x | 0.53x | 1.22x | 0.70x | 0.40x | 0.52x | 0.54x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |